Myeloma & AL Amyloidosis: Why Early Diagnosis Matters and How Research Can Help
Early diagnosis can make all the difference for multiple myeloma and AL amyloidosis patients, but delays are common. In this webinar, Dr. Nadine Abdallah will share findings from her HealthTree research, “AL Amyloidosis: Understanding the Clinical Prodrome and Delays in Diagnosis.” She’ll discuss how the study was conducted, key results, and why they matter to patients. Learn how you can help improve future research by participating in studies and surveys. A Patient Navigator, from HealthTree, will be available at the end of the webinar to answer any questions you have about HealthTree Cure Hub and how you can power lifesaving research. Don’t miss this important discussion!
Cynthia introduces the agenda of the event and featured speaker Dr. Nadine Abdallah
Dr. Nadine Abdallah shares insights from her research and ways to support future studies
Type your questions in the chat and we will answer them!
We'll have one of our patient navigators to help answering your questions!
Cynthia Cahoon, RN
Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.
Dr. Nadine Abdallah
Dr. Nadine H. Abdallah is an Assistant Professor in the Division of Hematology at Mayo Clinic in Rochester, MN. Her research focuses on understanding the impact of frailty, body composition, and social determinants of health on outcomes of older patients with myeloma patients, with the aim of personalizing care. She studies physical, radiological, and laboratory biomarkers of frailty and both pharmacologic and behavioral interventions to improve fitness, treatment outcomes, and quality of life in patients with multiple myeloma. Her work also incorporates digital health technologies to increase clinical trial access and minimize patient burdens.